Donor-specific HLA antibodies (DSA) has been associated with an increased risk of rejection and poorer graft outcomes.Short-term survival following desensitization has been demonstrated with acceptable outcomes.The mediumterm graft survival in Uruguay has not been studied. The objective is analyze the impact of pre-existing DSA in renal transplantation (RT) on medium-term graft survival (SV) and in the incidence of acute rejection (AR).
No takes yet. Share an insight, caveat, or question.
ACOSTA et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: